Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 193
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00376948 | Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | ||
| NCT00176813 | Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer | ||
| NCT00514215 | Cryotherapy and GM-CSF in Treating Patients With Lung Metastases or Primary Lung Cancer | ||
| NCT00520767 | Bortezomib, Melphalan, and Dexamethasone in Treating Patients With Primary Amyloidosis or Light Chain Deposition Disease | ||
| NCT07227831 | A Ph II Study of the TheraBionic P1 Device in Subjects With Hormone Positive Breast Cancer | ||
| NCT07118202 | TheraBionic P1 Device in Subjects With Advanced Hepatocellular Carcinoma | ||
| NCT01251952 | Dose Escalation Trial of Denileukin Diftitox (Ontak) Post Autologous Transplantation | ||
| NCT01051570 | Carboplatin, Everolimus, and Prednisone in Treating Patients With Metastatic Prostate Cancer That Progressed After Docetaxel | ||
| NCT02472275 | PLX3397, Radiation Therapy, and Antihormone Therapy in Treating Patients With Intermediate- or High-Risk Prostate Cancer | ||
| NCT00002552 | Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma | ||
| NCT00903214 | Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer | ||
| NCT00066326 | Imatinib Mesylate and 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Chronic Myelogenous Leukemia | ||
| NCT07218432 | A Study of the TheraBionic P1 Device in Breast Cancer | ||
| NCT00899665 | Proteases in Patients With Prostate Cancer That Has Spread to the Bone | ||
| NCT00011973 | Chemotherapy in Treating Patients With Advanced Kidney Cancer | ||
| NCT00028548 | XK469 in Treating Patients With Advanced Solid Tumors | ||
| NCT02723604 | Low-Level Laser Therapy for Prevention of Oral Mucositis | ||
| NCT00004024 | Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma | ||
| NCT00030420 | Celecoxib and Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer | ||
| NCT03453489 | AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm | ||
| NCT00078923 | Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate | ||
| NCT07095114 | A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breast Cancer Patients. | ||
| NCT00003171 | Bryostatin 1 in Treating Patients With Myelodysplastic Syndrome | ||
| NCT00016185 | Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors | ||
| NCT02359019 | MK-3475 as Maintenance Therapy in Extensive Stage SCLC | ||
| NCT01468532 | Docetaxel, Prednisone, and Pasireotide in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer | ||
| NCT02906241 | PACCT: Partnering Around Cancer Clinical Trials | ||
| NCT04397679 | Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma | ||
| NCT00918762 | Transoral Robotic Surgery or Standard Surgery in Treating Patients With Benign or Malignant Tumors of the Larynx and Pharynx | ||
| NCT01534143 | High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant | ||
| NCT01812668 | Cabozantinib-S-Malate in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer | ||
| NCT01420874 | Anti-CD3 x Anti-Erbitux® Armed Activated T Cells (Phase Ib) for Gastrointestinal (GI Cancer) | ||
| NCT03183050 | MEND 2: Making Treatment Decisions Using Genomic Testing | ||
| NCT01987596 | Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer | ||
| NCT02470559 | Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent | ||
| NCT01698658 | Ultrasound Tomography Using SoftVue in Diagnosing Women With Breast Cancer | ||
| NCT06439914 | First-in-human Study of Interferon-y PET Imaging to Assess Response to Immunotherapy | ||
| NCT06576115 | Gemcitabine, Nab-paclitaxel Plus the TheraBionic P1 (an Amplitude-Modulated Radiofrequency Electromagnetic Fields) Device to Treat Metastatic Pancreatic Cancer | ||
| NCT00717535 | Studying Umbilical Cord Blood From African-American Donors | ||
| NCT03719677 | Reducing Metabolic Syndrome Among Breast Cancer Survivors | ||
| NCT01958372 | Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer | ||
| NCT07130903 | Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer | ||
| NCT00618826 | A Study of Biweekly Gemcitabine, Paclitaxel, and Avastin in Patients With Metastatic Breast Cancer | ||
| NCT00459121 | Vandetanib, Carboplatin, and Paclitaxel in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Can Be Removed by Surgery | ||
| NCT03454529 | The Effect of Simvastatin on Breast Cancer Cell Growth in Women With Stage I-II Breast Cancer | ||
| NCT00369109 | Skin Biopsies and DNA Analysis in Patients Receiving Irinotecan or Gemcitabine For Advanced Solid Tumors | ||
| NCT03328091 | Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen) | ||
| NCT06537687 | Relational Agents in Cervical Cancer Education (RACE) | ||
| NCT01888198 | Ablation of Renal Masses Outcomes Registry (ARMOR): Ablation Procedure and Quality of Life Assessment | ||
| NCT01609816 | Dasatinib for Modulating Immune System After Autologous Stem Cell Transplants for Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma |
